PO.6.139 Effect and safety profile of belimumab and tacrolimus (B-T) combination therapy in 33 patients with systemic lupus erythematosus: a single-center retrospective analysis

MLA

Y Ikeda, et al. “PO.6.139 Effect and Safety Profile of Belimumab and Tacrolimus (B-T) Combination Therapy in 33 Patients with Systemic Lupus Erythematosus: A Single-Center Retrospective Analysis.” Lupus Science and Medicine, vol. 9, no. Suppl 2, Oct. 2022. EBSCOhost, https://doi.org/10.1136/lupus-2022-elm2022.159.

APA

Y Ikeda, M Okada, M Kishimoto, A Nomura, S Fukui, T Nakai, H Tamaki, A Kitada, & G Kidoguchi. (2022). PO.6.139 Effect and safety profile of belimumab and tacrolimus (B-T) combination therapy in 33 patients with systemic lupus erythematosus: a single-center retrospective analysis. Lupus Science and Medicine, 9(Suppl 2). https://doi.org/10.1136/lupus-2022-elm2022.159

Chicago

Y Ikeda, M Okada, M Kishimoto, A Nomura, S Fukui, T Nakai, H Tamaki, A Kitada, and G Kidoguchi. 2022. “PO.6.139 Effect and Safety Profile of Belimumab and Tacrolimus (B-T) Combination Therapy in 33 Patients with Systemic Lupus Erythematosus: A Single-Center Retrospective Analysis.” Lupus Science and Medicine 9 (Suppl 2). doi:10.1136/lupus-2022-elm2022.159.